| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |